ERC-AG-LS7
ERC-AG-LS7
Programme: H2020
89 projects · €209,113,287 total EU contribution (project-level) · 102 participating organizations · 18 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€209,113,287
Countries active
Participant organizations by country (headquarters in CORDIS).
- Italy (19)
- Germany (16)
- UK (13)
- Spain (12)
- Netherlands (11)
- France (5)
- CH (4)
- SE (4)
- NO (3)
- BE (2)
- CY (2)
- DK (2)
- FI (2)
- IL (2)
- EL (1)
- HU (1)
- IE (1)
- US (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- INSERM6 projects · FR
- KU Leuven4 projects · BE
- ERASMUS MC3 projects · NL
- HELSINGIN YLIOPISTO3 projects · FI
- UEDIN3 projects · UK
- UNIVERSITY COLLEGE LONDON3 projects · —
- Leiden University Medical Center2 projects · NL
- CSIC2 projects · ES
- GERMAN CANCER RESEARCH CENTER2 projects · DE
- HSR2 projects · IT
- INGM2 projects · IT
- IRFMN2 projects · IT
Projects
Page 3 of 9
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Investigating new therapeutic approaches to Friedreich's Ataxia FAST · 293699 | FP7 | €1,496,200 | €1,496,200 | Details |
Voxel Imaging PET Pathfinder VIP · 250207 | FP7 | €2,044,400 | €2,044,400 | Details |
Metabolomics of fungal diseases: a systems biology approach for biomarkers discovery and therapy FUNMETA · 293714 | FP7 | €2,299,200 | €2,299,200 | Details |
BRain dEvelopment and Air polluTion ultrafine particles in scHool childrEn BREATHE · 268479 | FP7 | €2,499,230 | €2,499,230 | Details |
Next Generation in-vivo imaging platform for post-genome biology and medicine MSOT · 233161 | FP7 | €1,999,992 | €1,999,992 | Details |
A Novel Non-Invasive Prenatal Diagnosis for Genetic Disorders NIPD · 322953 | FP7 | €2,500,000 | €2,500,000 | Details |
Novel vaccine generation for the treatment of cancer. A glyco-nanomedial approach instructing T cells GLYCOTREAT · 339977 | FP7 | €2,498,736 | €2,498,736 | Details |
Human Pluripotent Stem Cells: the new heart patient? STEMCARDIOVASC · 323182 | FP7 | €2,500,000 | €2,500,000 | Details |
The Impact of Privatization on the Mortality Crisis in Eastern Europe PRIVMORT · 269036 | FP7 | €3,483,058 | €3,483,058 | Details |
The use of genetic profiling to guide prostate cancer targeted screening and cancer care BARCODE · 339208 | FP7 | €2,499,123 | €2,499,123 | Details |